Zanzonico P - Search Results

1

Phase 1 study of intraventricular ¹³¹I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.

Kramer K, Pandit-Taskar N, Kushner BH, Zanzonico P, Humm JL, Tomlinson U, Donzelli M, Wolden SL, Haque S, Dunkel I, Souweidane MM, Greenfield JP, Tickoo S, Lewis JS, Lyashchenko SK, Carrasquillo JA, Chu B, Horan C, Larson SM, Cheung NV, Modak S. Kramer K, et al. Among authors: zanzonico p. J Hematol Oncol. 2022 Nov 12;15(1):165. doi: 10.1186/s13045-022-01383-4. J Hematol Oncol. 2022. PMID: 36371226 Free PMC article. Clinical Trial.

2

Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors.

Ugur O, Kothari PJ, Finn RD, Zanzonico P, Ruan S, Guenther I, Maecke HR, Larson SM. Ugur O, et al. Among authors: zanzonico p. Nucl Med Biol. 2002 Feb;29(2):147-57. doi: 10.1016/s0969-8051(01)00290-6. Nucl Med Biol. 2002. PMID: 11823119

3

Measurements of tumor tissue oxygen tension using a time-resolved luminescence-based optical oxylite probe: comparison with a paired survival assay.

Urano M, Chen Y, Humm J, Koutcher JA, Zanzonico P, Ling C. Urano M, et al. Among authors: zanzonico p. Radiat Res. 2002 Aug;158(2):167-73. doi: 10.1667/0033-7587(2002)158[0167:mottot]2.0.co;2. Radiat Res. 2002. PMID: 12105986

4

Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes.

Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo HF, Ivanova A, Balatoni J, Teruya-Feldstein J, Heller G, May C, Ponomarev V, Ruan S, Finn R, Blasberg RG, Bornmann W, Riviere I, Sadelain M, O'Reilly RJ, Larson SM, Tjuvajev JG. Koehne G, et al. Among authors: zanzonico p. Nat Biotechnol. 2003 Apr;21(4):405-13. doi: 10.1038/nbt805. Epub 2003 Mar 24. Nat Biotechnol. 2003. PMID: 12652311

5

Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI.

Palm S, Enmon RM Jr, Matei C, Kolbert KS, Xu S, Zanzonico PB, Finn RL, Koutcher JA, Larson SM, Sgouros G. Palm S, et al. J Nucl Med. 2003 Jul;44(7):1148-55. J Nucl Med. 2003. PMID: 12843231 Free article.

6

Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.

Zanzonico P, O'Donoghue J, Chapman JD, Schneider R, Cai S, Larson S, Wen B, Chen Y, Finn R, Ruan S, Gerweck L, Humm J, Ling C. Zanzonico P, et al. Eur J Nucl Med Mol Imaging. 2004 Jan;31(1):117-28. doi: 10.1007/s00259-003-1322-y. Epub 2003 Oct 2. Eur J Nucl Med Mol Imaging. 2004. PMID: 14523586

7

Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2.

Cheung NK, Modak S, Lin Y, Guo H, Zanzonico P, Chung J, Zuo Y, Sanderson J, Wilbert S, Theodore LJ, Axworthy DB, Larson SM. Cheung NK, et al. Among authors: zanzonico p. J Nucl Med. 2004 May;45(5):867-77. J Nucl Med. 2004. PMID: 15136638 Free article.

8

PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer.

Zanzonico PB, Finn R, Pentlow KS, Erdi Y, Beattie B, Akhurst T, Squire O, Morris M, Scher H, McCarthy T, Welch M, Larson SM, Humm JL. Zanzonico PB, et al. J Nucl Med. 2004 Nov;45(11):1966-71. J Nucl Med. 2004. PMID: 15534070 Free article. Clinical Trial.

9

Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.

O'Donoghue JA, Zanzonico P, Pugachev A, Wen B, Smith-Jones P, Cai S, Burnazi E, Finn RD, Burgman P, Ruan S, Lewis JS, Welch MJ, Ling CC, Humm JL. O'Donoghue JA, et al. Among authors: zanzonico p. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1493-502. doi: 10.1016/j.ijrobp.2004.12.057. Int J Radiat Oncol Biol Phys. 2005. PMID: 15817355

10

Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose.

Förster GJ, Santos EB, Smith-Jones PM, Zanzonico P, Larson SM. Förster GJ, et al. Among authors: zanzonico p. J Nucl Med. 2006 Jan;47(1):140-9. J Nucl Med. 2006. PMID: 16391198 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

263 results

Search Page